Patents by Inventor Junjun Wu

Junjun Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080128286
    Abstract: An electrode is described. The electrode includes a substrate having a first and a second surface, a conductive layer, multilayer structure having alternating layers of at least one polymer layer and at least one electroactive chemical bound nanoparticle layer. The conductive layer is disposed on the second surface of the substrate, and the multilayer structure is disposed on the conductive layer.
    Type: Application
    Filed: December 4, 2006
    Publication date: June 5, 2008
    Inventors: Junjun Wu, John E. Potts, Jung-Sheng Wu
  • Publication number: 20080128665
    Abstract: A nanoparticle thin film is described. An article includes a substrate and the nanoparticle thin film that includes nanoparticles having an average size from 5 nm to 50 nm, at least one electroactive chemical, and at least one organic binder material. The electroactive chemical binds to the surface of the nanoparticles. Also described are dispersions and coating compositions.
    Type: Application
    Filed: December 4, 2006
    Publication date: June 5, 2008
    Inventors: Junjun Wu, John E. Potts, Jung-Sheng Wu, James E. Thorson
  • Publication number: 20080131771
    Abstract: An electrolyte composition is described. The electrolyte composition includes at least one ionic compound; at least one polar solvent; at least one polymerizable material; at least one nanoparticle based viscosity modifier; at least one chain transfer agent; and at least one initiator. Also described are electrochromic articles and devices including an electrolyte layer including an electrolyte composition. Methods of assembling an electrochromic article are also included.
    Type: Application
    Filed: December 4, 2006
    Publication date: June 5, 2008
    Inventors: Junjun Wu, Brian T. Weber, Duane D. Fansler
  • Publication number: 20060264460
    Abstract: The present invention provides compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, m and n are defined as described herein. The invention also provides methods of making the compounds of formula (I), and methods of treating inflammatory diseases, such as rheumatoid arthritis, in a mammal comprising administering a therapeutically effective amount of a compound of formula (I) to the mammal.
    Type: Application
    Filed: May 18, 2006
    Publication date: November 23, 2006
    Applicant: Wyeth
    Inventors: Neal Green, Yonghan Hu, Neelu Kaila, Kristin Janz, Jennifer Thomason, Huan-Qiu Li, Rajeev Hotchandani, Junjun Wu, Ariamala Gopalsamy, Steve Tam, Lih-Ling Lin, John Cuozzo, Satenig Guler, Adrian Huang, Jeffrey condon
  • Patent number: 7130516
    Abstract: An optical waveguide comprises a core, an inner cladding laterally surrounding the core, and an outer cladding laterally surrounding the inner cladding, wherein the core, inner cladding, and outer cladding have a depressed well configuration. The waveguide operates in three or more wavelength bands, wherein a first wavelength band is centered at about 1300 nm, and wherein a second wavelength band is centered at about 1625 nm. The waveguide has bend losses that are less than or equal to 1.0 dB/turn when measured on a 5 mm radius bend at 1625 nm and bend losses that are less than or equal to 1.5 dB/turn when measured on a 5 mm radius bend at 1650 nm.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: October 31, 2006
    Assignee: 3M Innovative Properties Company
    Inventors: Junjun Wu, Craig R. Sykora
  • Publication number: 20060183790
    Abstract: The present invention provides an azolylacylquanidine compound of formula I The present invention also provides methods for the use thereof to inhibit ?-secretase (BACE) and treat ?-amyloid deposits and neurofibrillary tangles.
    Type: Application
    Filed: February 13, 2006
    Publication date: August 17, 2006
    Applicant: Wyeth
    Inventors: Derek Cole, Eric Manas, Lee Jennings, Frank Lovering, Joseph Stock, William Moore, John Ellingboe, Jeffrey Condon, Mohani Sukhdeo, Ping Zhou, JunJun Wu, Koi Morris
  • Publication number: 20060045451
    Abstract: An optical waveguide comprises a core, an inner cladding laterally surrounding the core, and an outer cladding laterally surrounding the inner cladding, wherein the core, inner cladding, and outer cladding have a depressed well configuration. The waveguide operates in three or more wavelength bands, wherein a first wavelength band is centered at about 1300 nm, and wherein a second wavelength band is centered at about 1625 nm. The waveguide has bend losses that are less than or equal to 1.0 dB/turn when measured on a 5 mm radius bend at 1625 nm and bend losses that are less than or equal to 1.5 dB/turn when measured on a 5 mm radius bend at 1650 nm.
    Type: Application
    Filed: August 3, 2005
    Publication date: March 2, 2006
    Inventors: Junjun Wu, Craig Sykora
  • Publication number: 20050239770
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I: Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-? expression utilizing compounds of the present invention are also disclosed.
    Type: Application
    Filed: June 2, 2005
    Publication date: October 27, 2005
    Inventors: Kevin Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn Erickson, Jeffrey Letourneau, Edward McDonald, Katerina Leftheris, Stephen Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John Baldwin, Alaric Dyckman
  • Patent number: 6906067
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I: Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-? expression utilizing compounds of the present invention are also disclosed.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: June 14, 2005
    Assignees: Bristol-Myers Squibb Company, Pharmaceopeia, Inc.
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John J. Baldwin, Alaric J. Dyckman
  • Publication number: 20040139766
    Abstract: Systems and methods for treating spools of fiber using recycled gas. Spools of fiber are placed in chambers which can be sealed for exposure to the treatment gas. When a chamber is closed and sealed the treatment gas is pumped into the chamber to a specified pressure temperature and pressure to react with the fiber. Upon completion of the reaction the gas is pumped from the chamber in order to facilitate the removal of the treated fiber. The gas can be evacuated with a vacuum pump and compressed to be stored in a pressure vessel for reuse. At this time the gas may be analyzed. If the concentration of a component is too low, the gas may be vented or it may be enriched so that it may be recycled; otherwise it is compressed for storage and the process is repeated.
    Type: Application
    Filed: January 17, 2003
    Publication date: July 22, 2004
    Inventors: Gene K. Weeks, Junjun Wu, Ramdane Assas, Kai H. Chang, Siu-Ping Hong
  • Publication number: 20020137747
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed.
    Type: Application
    Filed: June 26, 2001
    Publication date: September 26, 2002
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski, Zahid Hussain, Ian Henderson, Axel Metzger, John J. Baldwin, Alaric J. Dyckman
  • Publication number: 20020065270
    Abstract: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed.
    Type: Application
    Filed: December 22, 2000
    Publication date: May 30, 2002
    Inventors: Kevin Joseph Moriarty, Yvonne Shimshock, Gulzar Ahmed, Junjun Wu, James Wen, Wei Li, Shawn David Erickson, Jeffrey John Letourneau, Edward McDonald, Katerina Leftheris, Stephen T. Wrobleski